BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22211329)

  • 1. Correction and clarification regarding AFX and pleomorphic dermal sarcoma.
    McCalmont TH
    J Cutan Pathol; 2012 Jan; 39(1):8. PubMed ID: 22211329
    [No Abstract]   [Full Text] [Related]  

  • 2. AFX: what we now know.
    McCalmont TH
    J Cutan Pathol; 2011 Nov; 38(11):853-6. PubMed ID: 21955311
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical fibroxanthoma.
    Weedon D; Van Deurse M
    J Cutan Pathol; 2012 May; 39(5):565. PubMed ID: 22443422
    [No Abstract]   [Full Text] [Related]  

  • 4. I double dare me.
    McCalmont TH
    J Cutan Pathol; 2012 Jan; 39(1):5-7. PubMed ID: 22211328
    [No Abstract]   [Full Text] [Related]  

  • 5. Red is dead.
    McCalmont TH
    J Cutan Pathol; 2012 Mar; 39(3):315-6. PubMed ID: 22335589
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical fibroxanthoma.
    Ziemer M
    J Dtsch Dermatol Ges; 2012 Aug; 10(8):537-50. PubMed ID: 22709412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleomorphic spindle cell dermal neoplasm with dot-like keratin reactivity: keratin-positive AFX or carcinoma?
    Ellis R; Chase E; Barland A; Rajpara A; Fraga GR
    J Cutan Pathol; 2015 Nov; 42(11):847-52. PubMed ID: 26041010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.
    Folpe AL; Cooper K
    Arch Pathol Lab Med; 2007 Oct; 131(10):1517-24. PubMed ID: 17922587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
    Soleymani T; Tyler Hollmig S
    Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
    Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
    J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?
    Ricci C; De Leo A; Dika E; Lambertini M; Veronesi G; Corti B
    Acta Histochem; 2020 Feb; 122(2):151498. PubMed ID: 31889532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
    Soleymani T; Aasi SZ; Novoa R; Hollmig ST
    Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleomorphic Dermal Sarcoma.
    Saleh JS; Whittington CP; Bresler SC; Patel RM
    Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN; Dyck R; Weenig RH; Comfere NI
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma.
    Anders IM; Schimmelpfennig C; Wiedemann K; Löffler D; Kämpf C; Blumert C; Reiche K; Kunz M; Anderegg U; Simon JC; Ziemer M
    J Dtsch Dermatol Ges; 2023 May; 21(5):482-491. PubMed ID: 37035902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant fibrous histiocytoma, malignant melanoma and squamous cell carcinoma arising from different areas in an adult.
    Kurt M; Kilickap S; Aksoy S; Tekuzman G
    South Med J; 2005 Dec; 98(12):1228-9. PubMed ID: 16440931
    [No Abstract]   [Full Text] [Related]  

  • 18. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
    Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
    J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The many faces of Atypical fibroxanthoma.
    Agaimy A
    Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconsidering the diagnostic and prognostic utility of LN-2 for undifferentiated pleomorphic sarcoma and atypical fibroxanthoma.
    Hollmig ST; Rieger KE; Henderson MT; West RB; Sundram UN
    Am J Dermatopathol; 2013 Apr; 35(2):176-9. PubMed ID: 23000905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.